Retraction
A FBXO7/EYA2-SCFFBXW7 axis promotes AXL-mediated maintenance of mesenchymal and immune evasion phenotypes of cancer cells
Paper Information
Record ID:
53937
Author(s):
Journal:
Publication Date:
March 17, 2022
Retraction Date:
June 20, 2024
(1.4 year years ago)
Subjects:
Institutions:
- Tumor Initiation and Maintenance Program, NCI-Designated Cancer Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA 92037, USA
- University of Pittsburgh Medical Center Hillman Cancer Center, Pittsburgh, PA 15213, USA
- Division of Regenerative Medicine, Department of Medicine, University of California, San Diego, CA 92037, USA
- Department of Pathology, University of Cambridge, Tennis Court Road, Cambridge CB2 1QP, UK
- Misvik Biology Ltd., 20520 Turku, Finland
- Department of Biological Chemistry, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA 90095, USA
- KBiohub, Moraga, CA 94556, USA
- Department of Cell and Molecular Biology, Karolinska Institute, Stockholm 171 77, Sweden
- Department of Neurology, University of Pittsburgh, Pittsburgh, PA 15213, USA
Countries:
Article Type:
Publisher:
Elsevier - Cell Press
Open Access:
Yes
PubMed ID:
Retraction PubMed ID:
Retraction Details
Retraction Reasons:
Nature of Retraction:
Retraction
Retraction Notice:
10.1016/j.molcel.2024.05.022Citations (22)
22
Total Citations2
Post-Retraction(9.1%)
20
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
0
Within 30 days
1
Within 1 year
0
After 2+ years
369
Days since retraction (latest)
Smurf2 knockdown attenuates the progression of diabetic nephropathy by inhibiting mesangial cell proliferation and fibrosis through suppressing EYA2 ubiquitination
Li-Mei Chen, Yuqing Chen, Fei Liu et al. (4 authors)
Renal Failure
Open Access
Published: Jun 2025
369 days after retraction
Integrative spatial analysis reveals tumor heterogeneity and immune colony niche related to clinical outcomes in small cell lung cancer
Haiquan Chen, Chaoqiang Deng, Jian Gao et al. (25 authors)
Cancer Cell
Published: Feb 2025
4 citations
4 citations
226 days after retraction
FBXO7 ubiquitinates PRMT1 to suppress serine synthesis and tumor growth in hepatocellular carcinoma
Li Luo, Xingyun Wu, Jiawu Fan et al. (10 authors)
Nature Communications
Open Access
Published: Jun 2024
15 citations
15 citations
15 days before retraction
All eyes on Eya: A unique transcriptional co-activator and phosphatase in cancer
Connor J. Hughes, Christopher P Alderman, Arthur Wolin et al. (6 authors)
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
Published: Mar 2024
7 citations
7 citations
84 days before retraction
Study of an <i>FBXO7</i> patient mutation reveals Fbxo7 and <scp>PI</scp>31 co‐regulate proteasomes and mitochondria
Sara Al Rawi, Lorna Simpson, Guðrún Agnarsdóttir et al. (10 authors)
FEBS Journal
Open Access
Published: Mar 2024
5 citations
5 citations
101 days before retraction
Dysregulation of RNA splicing in early non-alcoholic fatty liver disease through hepatocellular carcinoma
Nicholas J. G. Webster, Deepak Kumar, Panyisha Wu
Scientific Reports
Open Access
Published: Jan 2024
10 citations
10 citations
142 days before retraction
Advances in targets in inflammatory breast cancer
Toshiaki Iwase, Xiaoping Wang, Lan Thi Phi et al. (6 authors)
International review of cell and molecular biology
Published: Jan 2024
171 days before retraction
UBXN9 inhibits the RNA exosome function to promote T cell control of liver tumorigenesis
Li Zhang, Kun Jiao, Yun Liu et al. (14 authors)
Hepatology
Published: Dec 2023
6 citations
6 citations
198 days before retraction
FBXW7 and human tumors: mechanisms of drug resistance and potential therapeutic strategies
Wanqing Wang, Kaipeng Jiang, Xue Liu et al. (8 authors)
Frontiers in Pharmacology
Open Access
Published: Nov 2023
8 citations
8 citations
220 days before retraction
FBXO7 Confers Mesenchymal Properties and Chemoresistance in Glioblastoma by Controlling Rbfox2‐Mediated Alternative Splicing
Shangbiao Li, Yanwen Chen, Yuxin Xie et al. (17 authors)
Advanced Science
Open Access
Published: Oct 2023
13 citations
13 citations
253 days before retraction
Serum extracellular vesicles with NSD1 and FBXO7 mRNA as novel biomarkers for gastric cancer
Zhen Wang, Juan Ding, Yilei Xiao et al. (7 authors)
Clinical Biochemistry
Open Access
Published: Sep 2023
3 citations
3 citations
272 days before retraction
EYA2 tyrosine phosphatase inhibition reduces MYC and prevents medulloblastoma progression
Arthur Wolin, Melanie Y. Vincent, Taylor Hotz et al. (22 authors)
Neuro-Oncology
Published: Jul 2023
7 citations
7 citations
335 days before retraction
Immune Checkpoint Blockade Therapy for Breast Cancer: Lessons from Epithelial–Mesenchymal Transition
Isabel O’Connell, Anushka Dongre
Molecular Diagnosis & Therapy
Open Access
Published: May 2023
2 citations
2 citations
401 days before retraction
FBXW7 attenuates tumor drug resistance and enhances the efficacy of immunotherapy
Shimin Chen, Jichun Lin, Jiaojiao Zhao et al. (8 authors)
Frontiers in Oncology
Open Access
Published: Mar 2023
9 citations
9 citations
464 days before retraction
Retinal determination gene networks: from biological functions to therapeutic strategies
Shuangli Zhu, Wanling Li, Hao Zhang et al. (6 authors)
Biomarker Research
Open Access
Published: Feb 2023
5 citations
5 citations
498 days before retraction
Discovery of AXL Degraders with Improved Potencies in Triple-Negative Breast Cancer (TNBC) Cells
Rui He, Zhiqiang Song, Yu Bai et al. (15 authors)
Journal of Medicinal Chemistry
Published: Jan 2023
17 citations
17 citations
512 days before retraction
Pan-cancer analysis of FBXW family with potential implications in prognosis and immune infiltration
Tingting Huang, XIaoxiao OuYang, Jiwei Li et al. (7 authors)
Frontiers in Immunology
Open Access
Published: Dec 2022
4 citations
4 citations
554 days before retraction
The characteristics of FBXO7 and its role in human diseases
Yeling Zhong, Jinyun Li, Meng Ye et al. (4 authors)
Gene
Published: Oct 2022
9 citations
9 citations
612 days before retraction
Cuproptosis patterns and tumor immune infiltration characterization in colorectal cancer
Yan Du, Yilin Lin, Bo Wang et al. (11 authors)
Frontiers in Genetics
Open Access
Published: Sep 2022
19 citations
19 citations
646 days before retraction
Recent Insight on Regulations of FBXW7 and Its Role in Immunotherapy
L. Xing, Leidi Xu, Yong Zhang et al. (10 authors)
Frontiers in Oncology
Open Access
Published: Jun 2022
10 citations
10 citations
727 days before retraction
Identification of Biomarkers Associated With CD8+ T Cells in Coronary Artery Disease and Their Pan-Cancer Analysis
Shijian Zhao, Yinteng Wu, Yantao Wei et al. (5 authors)
Frontiers in Immunology
Open Access
Published: Jun 2022
18 citations
18 citations
730 days before retraction
Dissecting the Role of AXL in Cancer Immune Escape and Resistance to Immune Checkpoint Inhibition
Agnete S. T. Engelsen, Maria L. Lotsberg, Raefa Abou Khouzam et al. (7 authors)
Frontiers in Immunology
Open Access
Published: Apr 2022
53 citations
53 citations
785 days before retraction
Quick Stats
Total Citations:
22
Years Since Retraction:
1.4 year
Open Access:
Yes
Last Checked:
Jul 24, 2025